logo

Frequently asked questions and glossary

Home
Portfolio / Request a test
What tests are best for you?
Bowel cancer test
10 facts about bowel cancer
Indigestion test - Helicobacter
FAQs and Glossary
Health Screening News
About Us
Contact Us

FAQS

What is screening?
Screening means attempting to identify a disease in a population of apparently healthy people with no symptoms of the disease. Screening cannot diagnose disease. An abnormal result only means that there is a higher chance of that person having the disease but no screening test is 100% effective.

What are the benefits of screening?
Diseases detected by screening can often be treated successfully because the disease is less advanced. This applies particularly to screening for cancer. Cancers detected before they have produced symptoms are less likely to have spread and frequently. For example, colonic cancer screening detects polyps in the bowel that precede the development of a cancer. By taking part in screening you can reduce your risk of dying from colonic cancer.

Is there cancer screening in the NHS?
There is no general population screening for prostate cancer on the NHS except for persons at high risk.
Colon cancer screening will start in April 2006 in the NHS for colon cancer screening but only  for people between 60 and 70 years (other bodies recommend screening from age 50). Neither will the NHS use the most up to date test as the NHS test does not distinguish between blood from meat in the diet and human blood. However, the test is still effective at detecting disease.
The NHS screening programmes for breast and cervical cancer are very effective and women should take advantage of these excellent programmes.

Who should be screened for cancer?
Men and women with no known risk factors should be tested every year from the age of 50 (American Cancer Society recommendation for colon cancer).

What are the special risk factors for cancer?
Previous cancer, a family history (parent, sibling or child of yours) of cancer or recognised cancer precursor eg colonic polyp
 
How often should you be screened?
Every 12-24 months. If you take a test with Oxford Screening we will remind you when your next test is due.

How long does it take to receive the result?
Normally, results are available within 72 hours for most tests but some tests take up to 5 working days (Monday - Friday) of receiving the sample.

How much do the tests and advice cost?
The all inclusive prices vary from £14.99 for a single test to £44.99 for a pack of 3 tests. Interpretation of the test results is part of the service and in the event of a positive test you will receive specific medical advice and recommendations on the next steps to take. Payment is by credit card online through a secure internet connection.
If you need to phone for any reason please be prepared to leave a message.
Are all screening tests the same?
We have selected a range of tests to suit most people's requirements whist concentrating on convenient home tests.


What happens if your test is negative?
You will receive your result by email along with standard medical advice.

What happens if your test is positive?
You will receive your result by letter, along with medical advice on what to do next. All positive results will be followed up by a telephone call. Discussion about the best course of action to follow a positive test is part of the service of Oxford Screening; we are not just a results service.

What are the chances of a positive test and what are the implications?
If there are no special risk factors, the chances of a positive bowel cancer test (FOB) test are less than 2 in 100 and of every 1000 people tested 1 or 2 will have a cancer and 3 or 4 will have polyps. Other tests are required to positively identify polyps or cancers and these include colonoscopy, sigmoidoscopy, barium enema or virtual colonoscopy. The chances of a positive test are related to age; people in their 60s have double the risk of a positive test to those in their 50s but the NHS in England does not plan to screen people under 60 unless they are at special risk.

For the prostate PSA test the chances of a positive test increase with age but most positive tests do not lead to a diagnosis of cancer because screening tests are primarily designed to be sensitive (detect disease) rather than be very specific (false positive tests are common with any screening test).

What are the risks of screening?
The NHS provides this list of the risks;
Being told you have the disease or even being treated for it when you don’t have it (because the test is wrong – false positive)

Being told you don’t have the disease when you do and so being falsely reassured (because the test is wrong – false negative)

Being told you need to be tested again so you may feel anxious

Being physically hurt by the screening test (for example you may need further tests that involve removing tissue from your bowel)”

Glossary

 

If there are any other terms that you think would be worth adding to those below please let me know and I will add them to the list!

 

Barium enema – An X-ray examination of the large bowel that is commonly used to find polyps and cancers. People who have had a positive FOB test may be asked to have a barium enema.

 

Cancer – A malignant tumour, that is, a tumour that has the capacity to spread locally and also to distant tissues and organs. A cancer treated before it has spread widely is less likely to be fatal.

 

Colonoscopy – An examination of the lower (large) bowel using a flexible scope. Polyps can be removed during the procedure and small tissue samples (biopsies) taken from any areas that appear to be malignant eg an ulcer or large polyp. People who have had a positive FOB test may be asked to have a colonoscopy.

 

Faeces – Sometimes referred to as ‘stool’.

 

Haemoglobin – The component of blood that carries oxygen and the part of blood that is detected by FOB testing.

 

Haemorrhoids – Dilated veins around the anus that can bleed and result in a falsely positive FOB screening test.

 

Hereditary – Conditions that run in families due to passing on of a genetic abnormality are called hereditary. This includes conditions that increase the risk of colon cancer eg. Familial adenomatous polyposis coli.

 

Inflammatory bowel disease – Conditions of the bowel (intestines) that cause abdominal pain and diarrhoea. The bowel lining is frequently ulcerated and bleeds. People with inflammatory bowel disease have a slightly increased risk of developing colon cancer. The two commonest types of inflammatory bowel disease are ulcerative colitis and Crohn’s disease. Screening for colon cancer should start at a younger age in people with inflammatory bowel disease.

 

Monoclonal antibody – A molecule that will attach specifically to another molecule. The monoclonal antibody used in the Actim FOB test will bind to a specific part of the human globin molecule in human haemogloblin.

 

Polyp – A localised tumour that can have a narrow stalk or a wide base. Some polyps can develop into cancers over a period of years. Removing polyps can prevent cancers later in life. Polyps have a tendency to bleed and screening for sub-microscopic amounts of blood can bring them to your doctor’s attention.

 

 

Sigmoidoscopy – Similar to colonoscopy but only examines the lowermost part of the bowel using a rigid rather than a flexible scope. Generally used if there is fresh blood in the faeces suggesting that the bleeding is coming from the last part of the bowel.

 

Sensitivity – If 1000 people are screened with an FOB test and only 10 of those people have a colon cancer or polyp, if all 10 people have a positive test, the sensitivity of the test is 100%. If 9 of the 10 people with a cancer or polyp have a positive test then the sensitivity is 90%. The sensitivity of the Actim FOB test is around 89% so that nearly all, the people with a disease will be detected. No screening test is 100% accurate.

 

Specificity – If 990 of 1000 people tested with an FOB test do not have a cancer or a polyp but 90 of them have a positive test then the specificity is 91% (900/990). You can see that even when the test specificity is very good, many people can have tests that are falsely positive. In this example there are nearly 10 times more people with positive screening tests that do not have disease than do have disease. Unfortunately this is the nature of screening. Very highly specific screening tests are rare.

 

Virtual colonoscopy – A modern version of colonoscopy that is done by imaging the bowel from outside the body. This test is very attractive because no instrument has to be inserted into the body but it is not widely available yet except in a few private centres.

 

 

Oxford Screening